PACTR (Pan African Clinical Trials Registry) certifiedNHREC & NAFDAC certified

Active Trial

Malaria vaccine

Sponsor

Pharma B

Expected Enrollment

200

Duration

10 mths

Protocol

v2.1

Status

Closed

SITE-ID: LAG-RC-2024

Trial request: Malaria vaccine Trial

A multicenter, randomized, double-blind study evaluating the safety, immunogenicity, and efficacy of a malaria vaccine candidate in preventing Plasmodium falciparum infection among healthy participants.

Compliance note

Accepting this invitation will add this trial to your site and move it into the setup phase. You'll then be able to configure your site before enrolling participants.

Key requirements

Facilities Needed

Cold storage (-80°C and -20°C) required
Infusion suite (min. 4 chairs)

Staff Allocation

3 Clinical research coordinatorsLab coordinatorPI (Principal Investigator)

Trial Audit History

  1. Invitation received

    24-MAY-2024 09:12:44 GMT

Sponsor Profile

Pharma B (Roche)

Department of malariology

Primary contact
Adewale Okoro
Therapeutic area
Malariology
Email
A.Okoro@pharma-b.ch
Protocol ID
PHB-2824-ONC-011

Documents

  • PDFProtocol.pdf
  • PDFInvestigator_Brochure.
  • DOCSite_Agreement_Draft.